Pozen (POZN) Inactive 10-K2009 FY Annual report

Filed: 9 Mar 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abuse, adjacent, adpotion, afflict, AICPA, al, alert, Angela, arm, arthritic, ASC, authoritative, BA, Bhatt, Bisulfate, body, bone, bony, break, burn, carryback, cartilage, century, Cermak, chosen, circumstance, clopidogrel, Codification, COGENT, colorectal, complicated, conflicting, corrected, Council, CPA, crossover, Cum, dealing, debarment, degenerative, destruction, developmental, disability, Drexel, dyspepsia, Education, Elizabeth, energy, erosive, expansion, exploit, extremely, float, Franklin, fraudulent, GAAP, glide, grow, hinder, illegal, immune, implication, imposition, inadvertent, incurrence, inhibit, inhibition, Inspector, interaction, JD, Lancaster, largest, Larson, Laude, layer, literature, MBA, McNeil, MD, men, metacloprimide, mild, mirror, modulate, neoplasia, nongovernmental, OIG, oversee, PDMA, penalty, Philadelphia, physical, platelet, Plavix, play, Prilosec, proven, qui, randomized, Rebate, Reconciliation, rub, seasoned, shape, shock, short, smooth, Spanish, Specialty, stringent, suggested, suggesting, surface, swelling, tam, tangible, Teva, thousand, throbbing, TIMI, train, training, transform, transforming, Unadited, VIMOVO, VIMOVOTM, vivo, women, younger

Removed: aching, AG, allocate, ancillary, anniversary, APB, approvability, back, calendar, cancel, cancelable, canceled, cancer, clear, collaborate, consulting, convert, convince, debilitating, delegated, display, documented, Emerging, EPS, Essentially, exclusively, fifteenth, FIN, financed, heart, historically, idea, incorporate, ingredient, Kingdom, Knoxville, Lek, lornoxicam, MHRA, path, percentage, permanent, permanently, persisted, Peter, Pharma, prevail, prospective, provisional, purpose, Reese, refuse, regular, renewed, requesting, resulting, retrospective, SAB, statistically, straightline, substance, Task, Tennessee, transition, UK, Wise

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

POZN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CFO CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

In connection with the Annual Report on Form 10-K of POZEN Inc. (the “Company”) , as filed with the Securities and Exchange Commission (the “Report”), I, William L. Hodges, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 9, 2010		/s/ William L. Hodges
		William L. Hodges
		Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.